Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
29.5 DKK | +1.72% | -5.21% | +6.01% |
Apr. 23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 23 | Embla Medical hf. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 869M 6.08B | Sales 2025 * | 945M 6.61B | Capitalization | 1.77B 12.41B |
---|---|---|---|---|---|
Net income 2024 * | 72M 504M | Net income 2025 * | 86M 602M | EV / Sales 2024 * | 2.52 x |
Net Debt 2024 * | 412M 2.88B | Net Debt 2025 * | 383M 2.68B | EV / Sales 2025 * | 2.28 x |
P/E ratio 2024 * |
23.6
x | P/E ratio 2025 * |
19.8
x | Employees | 4,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.4% |
Latest transcript on Embla Medical hf.
1 day | +0.34% | ||
1 week | -5.21% | ||
Current month | -13.13% | ||
1 month | -10.74% | ||
3 months | -1.85% | ||
6 months | +12.79% | ||
Current year | +6.01% |
Managers | Title | Age | Since |
---|---|---|---|
Sveinn Sölvason
CEO | Chief Executive Officer | 46 | 08-12-31 |
Director of Finance/CFO | 58 | 22-08-31 | |
Lukas Märklin
COO | Chief Operating Officer | - | 23-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 13-02-28 | |
Niels Jacobsen
CHM | Chairman | 66 | 04-12-31 |
Svafa Grönfeldt
BRD | Director/Board Member | 59 | 08-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 29.5 | +1.72% | 3 257 |
24-04-30 | 29 | -2.36% | 6,879 |
24-04-29 | 29.7 | +1.71% | 7,105 |
24-04-26 | 29.2 | 0.00% | 27,150 |
24-04-25 | 29.2 | -5.19% | 13,134 |
Delayed Quote Nasdaq Copenhagen, May 01, 2024 at 04:33 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.01% | 1.77B | |
-6.92% | 16.61B | |
+6.19% | 13.83B | |
+11.69% | 10.5B | |
-13.54% | 2.16B | |
+39.70% | 1.71B | |
+12.09% | 584M | |
-.--% | 423M | |
+25.00% | 132M | |
+25.30% | 96.01M |
- Stock Market
- Equities
- EMBLA Stock